Prof. Ljungman is professor of hematology, Dept. of Medicine Huddinge, Karolinska Institutet and acting director, Dept. of Allogeneic Stem Cell Transplantation, Karolinska University Hospital, Stockholm, Sweden. He was previously director, Dept. of Hematology, Huddinge University/Karolinska University Hospital 1998-2013
Prof Ljungman is a specialist in hematology and internal medicine in Sweden and has a Ph.D. in virology from Karolinska Institutet. He has also been a postdoc fellow at the Fred Hutchinson Cancer Research Center, Seattle, WA (1986-87), visiting professor, University of Florida, Gainesville, FL, USA (2013-2015), and an alternate member of the Committee for Advance Therapy, EMA, London, UK (2008-2011).
His main clinical field is management of patients undergoing allogeneic stem cell transplantation. His research interests are in two major field: diagnosis and management of viral infections, including studies of antiviral drugs in immunocompromised patients and immunizations of the immunocompromised patient. He has held several elected positions in international scientific societies such as chair of the Infectious Diseases Working Party and secretary, European Society for Blood and Marrow Transplantation (EBMT), and council member, vice president, and president, International Immuncompromised Host Society. Prof. Ljungman has authored more than 300 peer-reviewed publications, several book chapters, and is also co-editor of the book Transplant Infections now in its 4th edition.
Prof. Dr. Per Ljungman
(Karolinska University Hospital, Stockholm, Sweden)